Skip to content

Natural History of Cardiac and Respiration Function in Patients With Muscular Dystrophies on Home Mechanical Ventilation

Natural History of Cardiac and Respiratory Function in Patients With Muscular Dystrophies on Home Mechanical Ventilation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02501083
Enrollment
350
Registered
2015-07-17
Start date
2016-07-31
Completion date
2018-11-30
Last updated
2018-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart, Respiratory, Disease, Functional

Keywords

cardiomyopathy, echocardiography, prognosis, respiratory, home mechanical ventilation, vital capacity, maximal inspiratory pressure, maximal expiratory pressure

Brief summary

Muscular dystrophies are inherited disorders that affect skeletal muscle. Cardiac and respiratory function may be affected in this group of diseases. The investigators sought to analyze the long term cardiac and respiratory function in patients with muscular dystrophies recquiring home mechnaical ventilation .

Detailed description

Muscular dystrophies are neuromuscular disorders with disability and can affect respiratory muscle function and left ventricular function. Medical management of patients with cardiomyopathy relies mainly on angiotensin-converting-enzyme inhibitors and beta blockers. Respiratory management relies on home mechanical ventilation and couph assist. The investigators aim * to analyze cardiac and respiratory function over time in patients with muscular dystrophies followed at the home mechanical ventilation unit. * to determine the long term impact of the home mechanical ventilation on cardiac and respiratory events and to define the predictive factors associated. Patients will be included retrospectively. Tissue Doppler imaging and Tricuspid annular plane systolic excursion were used for the assessment of the right ventricle. Left ventricular ejection fraction was used for the analysis of the left ventricle. Respiratory function was assessed using the vital capacity, the maximal inspiratory pressure, the maximal expiratory pressure, the peak couph flow rate.

Interventions

OTHERno intervention

The study will not include any intervention.

Sponsors

Centre d'Investigation Clinique et Technologique 805
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age higher or equal to 18 years * Duchenne muscular dystrophy * Becker muscular dystrophy * Sarcoglycanopathy * limb girdle muscular dystrophy * Pompe disease * Steinert disease * FSH disease * Others myopathies

Exclusion criteria

* Minor patient * Sepsis condition

Design outcomes

Primary

MeasureTime frame
predictive factors for long term survival10 years

Secondary

MeasureTime frame
predictive factors for respiratory events10 years
cumulative cardiac events incidence10 years
cumulative respiratory events incidence10 years
predictuve factors for cardiac events10 years
annual rate of respiratory vital capacity decline10 years
annual rate of maximal inspiratory pressure decline10 years
annual rate of maximal expiratory pressure decline10 years
annual rate of left ventricular ejection fraction decline10 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026